Revenio Group posts increased EPS in Q1 2019.

NORDIC BUSINESS REPORT-April 17, 2019-Revenio Group posts increased EPS in Q1 2019

(C)2019 M2 COMMUNICATIONS http://www.m2.com

Revenio Group Oyj (HEL:REG1V), a Finnish, globally operating health technology corporation focused on a strongly patented intraocular pressure measurement technology, reported on Tuesday undiluted EPS of EUR0.086 for the first quarter of 2019, from January 2019 to March 2019. This compares with undiluted EPS of EUR0.069 in Q1 of the prior year.

EBITDA for the quarter totalled EUR2.9m or 34% of net sales, up by 27.2% as compared with EBITDA of EUR2.2m in the first quarter of the prior year.

Operating profit totalled EUR2.6m, or 30.6% of net sales, up by 20.8% as compared with EUR2.1m in first quarter of 2018.

Net sales for the quarter totalled EUR8.4m, up by 20.7% as compared with EUR7.0m in first quarter of 2018. The currency-adjusted growth of net sales in January to March 2019 was 15.6%.

Also, due to the acquisition of the Italian company...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT